1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FXYD6 CTRPv2 pan-cancer AAC 0.24 1e-10
mRNA RP3-403A15.5 CTRPv2 pan-cancer AAC 0.24 7e-09
mRNA KCNC1 CTRPv2 pan-cancer AAC 0.24 2e-09
mRNA C14orf132 CTRPv2 pan-cancer AAC 0.25 9e-09
mRNA ATL1 CTRPv2 pan-cancer AAC 0.25 3e-11
mRNA IRF2BP2 CTRPv2 pan-cancer AAC 0.25 3e-12
mRNA SATB1 CTRPv2 pan-cancer AAC 0.25 7e-12
mRNA ARHGAP33 CTRPv2 pan-cancer AAC 0.25 5e-12
mRNA ELAVL4 CTRPv2 pan-cancer AAC 0.25 6e-07
mRNA SOGA3 CTRPv2 pan-cancer AAC 0.25 4e-09
Download CSV